29 June 2017 - The U.S. FDA today allowed marketing of ClearLLab Reagents (T1, T2, B1, B2, M), the first ...
29 June 2017 - Today, the U.S. Food and Drug Administration unveiled a strategic plan to eliminate the agency’s existing ...
29 June 2017 - The divisions and infighting plaguing the GOP’s efforts to repeal and replace Obamacare are contagious — ...
28 June 2017 - Approval of 10 mg dose would provide physicians another option to customise patient treatment plans. ...
28 June 2017 - The acid test of any nation’s health care reform happens with a change in national administration. ...
28 June 2017 - "We don't play a role in drug pricing, but we do affect drug competition," Dr. Scott Gottlieb ...
28 June 2017 - Senate Republican leaders faced calls from critics within the party on Wednesday for substantial changes, rather ...
28 June 2017 - With substantially higher costs for abuse-deterrent formulations, and uncertainty regarding their impact on abuse, diversion, and switching ...
27 June 2017 - Facing a potentially disastrous defeat by members of his own party, U.S. Senate Majority Leader Mitch ...
27 June 2017 - ICER drug assessment reports to support VA drug coverage and price negotiation with pharmaceutical companies to ...
27 June 2017 - Agency takes important steps under new Drug Competition Action Plan. ...
26 June 2017 - While Washington wrangles with a replacement for Obamacare, patients across the country continue to battle one ...
26 June 2017 - Senate Republicans’ bill to erase major parts of the Affordable Care Act would cause an estimated ...
26 June 2017 - Novel synthetic biotic medicine, SYNB1020, under development for the treatment of hyperammonemia due to urea cycle disorders. ...
26 June 2017 - Twenty-two million Americans would lose insurance over the next decade under the healthcare bill drafted by ...